Showing results (1081-1090 of 1,445) with videos related to

Sort By:
Pageof 145
Molecular Therapy. Advances|May 15, 2026
IL-12-engineered human PSMA-CAR T cells for the treatment of advanced prostate cancerLupita S Lopez, Ziyou Cui, Yukiko Yamaguchi, et al.
International Journal of Systematic and Evolutionary Microbiology|September 27, 2013
Lactococcus formosensis sp. nov., a lactic acid bacterium isolated from yan-tsai-shin (fermented broccoli stems)Yi-Sheng Chen, Misa Otoguro, Yu-Hsuan Lin, et al.
Journal for Immunotherapy of Cancer|June 21, 2022
Antibody-based redirection of universal Fabrack-CAR T cells selectively kill antigen bearing tumor cellsYi-Chiu Kuo, Cheng-Fu Kuo, Kurt Jenkins, et al.
Cancer Immunology, Immunotherapy : CII|August 16, 2008
Total HLA class I loss in a sarcomatoid renal carcinoma cell line caused by the coexistence of distinct mutations in the two encoding beta2-microglobulin genesChin-Hsuan Hsieh, Ya-Jan Hsu, Chien-Chung Chang, et al.
Frontiers in Immunology|December 5, 2018
Effective Targeting of TAG72<sup>+</sup> Peritoneal Ovarian Tumors via Regional Delivery of CAR-Engineered T CellsJohn P Murad, Anna K Kozlowska, Hee Jun Lee, et al.
Cancer Biotherapy & Radiopharmaceuticals|September 7, 2021
Chelation-Tamoxifen Conjugates for Imaging of Estrogen ReceptorsSkye Hsin-Hsien Yeh, Wei-Chung Chang, Shu-Meng Hsu, et al.
American Journal of Cancer Research|July 16, 2025
Exploring the role of YES1 kinase in regulating cisplatin resistance through iTRAQ-based quantitative proteomic analysis in urothelial carcinomaChia-Che Wu, Chung-Wen Kuo, Ming-Chun Kuo, et al.
JAMA Network Open|February 6, 2025
Cannabis Use Disorder Emergency Department Visits and Hospitalizations and 5-Year MortalityDaniel T Myran, Michael Pugliese, André J McDonald, et al.
CNS Drugs|October 3, 2020
Antipsychotics and Risk of Neuroleptic Malignant Syndrome: A Population-Based Cohort and Case-Crossover StudyKim S J Lao, Jiaxi Zhao, Joseph Edgar Blais, et al.
Journal of Magnetic Resonance Imaging : JMRI|May 9, 2017
Response assessment of stereotactic body radiation therapy using dynamic contrast-enhanced integrated MR-PET in non-small cell lung cancer patientsYu-Sen Huang, Jenny Ling-Yu Chen, Feng-Ming Hsu, et al.
Pageof 145